Ad-hoc | 28 February 2008 18:22
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Merger
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Berlin, 28 February 2008 – Eckert & Ziegler Strahlen- und Medizintechnik AG
(ISIN DE 0005659700) and IBt s.a. have reached an agreement about the
consolidation of their respective Businesses for Prostate Cancer Implants
and executed a Share Contribution Agreement, in which Eckert & Ziegler
sells its Implant Business to IBt with immediate effect in exchange for
6.75 million IBt shares. As a result, Eckert & Ziegler will become IBt’s
largest shareholder, owning about 40% of all rights to dividends and other
economic benefits, and close to 30% of the voting rights in IBt’s
shareholder meeting. The difference in the two ratios is due to the
existence of so-called Beneficiary Shares, which only convey voting rights
in the shareholder meeting, but not to dividends.
Further details are provided in a press release which is available on the
company’s homepage.
The Executive Board
For enquiries please contact:
Eckert & Ziegler AG
Thomas Scheuch, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-139, Fax -112, E-mail: thomas.scheuch@ezag.de,
www.ezag.de
28.02.2008 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------